Zebra Capital Management LLC Vericel Corp Transaction History

Zebra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$31.69 - $43.29 $176,069 - $240,519	-5,556 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$35.2 - $52.6 $19,993 - $29,876	-568 Reduced 9.27%	5,556 $218,000
Q3 2021 Nov 15, 2021	SELL	$46.35 - $59.75 $62,804 - $80,961	-1,355 Reduced 18.12%	6,124 $299,000
Q2 2021 Aug 16, 2021	SELL	$47.2 - $67.81 $15,859 - $22,784	-336 Reduced 4.3%	7,479 $393,000
Q1 2021 May 17, 2021	BUY	$30.93 - $59.48 $241,717 - $464,836	7,815 New	7,815 $434,000

276

48.5M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.61B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.